Black Diamond Therapeutics (BDTX) Other Operating Expenses (2018 - 2025)
Black Diamond Therapeutics (BDTX) posted Other Operating Expenses of $7.3 million for Q4 2025, up 141.23% on a QoQ basis from $3.0 million in Q4 2018.
Black Diamond Therapeutics (BDTX) Other Operating Expenses (2018 - 2025) Analysis & Trends
Black Diamond Therapeutics' Other Operating Expenses history runs 2 years deep, the most recent figure standing at $7.3 million for Q4 2025.
- Quarterly Other Operating Expenses changed N/A year-over-year to $7.3 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $7.3 million (changed N/A YoY) and the FY2025 annual result came in at $7.3 million, changed N/A from the prior year.
- Other Operating Expenses was $7.3 million for Q4 2025 at Black Diamond Therapeutics, up from $3.0 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $7.3 million in Q4 2025 and bottomed at $7.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.35 Mn |
| Dec 31, 2018 | 3.05 Mn |